News Archive
Listed below are the latest news headlines posted to the Network of Care for The Network of Care for Mental / Behavioral Health Services. You can also use the search
box to find archived news headlines by keyword. You can also use the search box to find archived news headlines by keyword.
Drug pricing reform talks with US government lack clarity, industry executives say
By Bhanvi Satija and Christy Santhosh
6/10/2025
Recursion to lay off 20% of workforce amid biotech funding woes
By Mariam Sunny
6/10/2025
Vaccine stocks muted as Wall Street takes 'wait and watch' approach after Kennedy's shake-up
By Sriparna Roy and Bhanvi Satija
6/10/2025
US NIH director hopes administration will settle with universities over suspended grants
By Ahmed Aboulenein
6/10/2025
Factbox-Vaccine actions and policy positions under US Health Secretary Kennedy
6/10/2025
Metsera rises as experimental weight-loss drug shows promise in small early-stage trial
6/10/2025
US FDA places clinical hold on Gilead trials testing HIV pill combination
6/10/2025
Insmed's drug for rare lung disease achieves 'home run' in mid-stage trial
By Kamal Choudhury
6/10/2025
US appeals court confirms patent validity of Acadia's Parkinson's drug
6/9/2025
NIH scientists speak out over estimated $12 billion in Trump funding cuts
By Chad Terhune
6/9/2025
Mpox is still a health emergency, WHO says
6/9/2025
No drug price pledges by Pfizer, others in talks with US government, Pfizer CEO says
By Michael Erman
6/9/2025
Sixth Street-backed Caris Life Sciences targets $5.3 billion valuation in US IPO
6/9/2025
Kennedy dismisses entire US CDC vaccine panel, replacing all 17 members
By Ahmed Aboulenein and Michael Erman
6/9/2025
US FDA approves Merck's RSV antibody for infants
6/9/2025
Merck's potential blockbuster cholesterol pill succeeds in late-stage studies
6/9/2025
Exclusive-UnitedHealth eyes $1 billion deal to exit Latin America as insurer refocuses on US, sources say
By Tatiana Bautzer and Sabrina Valle
6/9/2025
Republican lawmaker’s raucous town hall reflects challenges in promoting Trump's bill
By Helen Coster
6/9/2025
Digital health company Omada valued at $1.3 billion as shares jump in Nasdaq debut
6/6/2025
Texas health department reports no additional measles cases in the state since June 3
6/6/2025
Experts doubt FBI’s claim that crop fungus smuggled by Chinese students is a threat
By Heather Schlitz
6/6/2025
Contraceptives for poorest countries stuck in warehouses after US aid cuts
By Jennifer Rigby
6/6/2025
Canada's Ontario province reports death of child from measles
6/5/2025
Story withdrawn on New York, other states urge FDA to expand access to abortion pill
6/5/2025
Virtual chronic care provider Omada Health raises $150 million in US IPO
6/5/2025
Walmart's Sam's Club to remove synthetic dyes from private brand by year end
6/5/2025
Humana to back curbs to Medicare Advantage billing practices, WSJ reports
6/5/2025
US faces vape shortage as China tariffs, seizures hit Geek Bar
By Emma Rumney
6/5/2025
US COVID vaccine recommendations sow confusion among doctors, insurers
By Julie Steenhuysen and Amina Niasse
6/5/2025
US Health Secretary Kennedy looks to fast-tracking approvals for rare disease drugs
By Sneha S K and Sriparna Roy
6/5/2025
23andMe seeks new bids after $305 million offer from its co-founder
By Dietrich Knauth
6/4/2025
Brazil agriculture minister: signs show efficient control of bird flu outbreak
By Lisandra Paraguassu
6/4/2025
Trump tax bill would increase number of uninsured by 11 million, CBO says
6/4/2025
Exclusive-CDC expert resigns from COVID vaccines advisory role, sources say
By Julie Steenhuysen, Michael Erman and Dan Levine
6/3/2025
Moderna agrees to true placebo-controlled trial of new COVID vaccine, Kennedy says
6/3/2025
Exclusive-Wegovy use up 50% among US teens
By Chad Terhune and Robin Respaut
6/3/2025
Trump administration scraps Biden-era policy on emergency abortions
By Nate Raymond
6/3/2025
Judge extends ban on Trump administration canceling COVID school aid
By Jonathan Stempel
6/3/2025
Sanofi to buy US biopharma group Blueprint for up to $9.5 billion
By Dominique Patton and Geert De Clercq
6/2/2025
US FDA launches AI tool to reduce time taken for scientific reviews
6/2/2025
UnitedHealth plans to earn back shareholder trust, CEO says
6/2/2025
Harvard seeks end to US funding cuts, says national security, public health research in peril
By Tom Hals
6/2/2025
Bristol Myers agrees up to $11.1 billion deal with BioNTech to shake up cancer immunotherapy
By Michael Erman and Ludwig Burger
6/2/2025
Amgen drug cuts small cell lung cancer death risk by 40%
By Deena Beasley
6/2/2025
Regeneron's weight-loss drug combo helps preserve muscle in study
6/2/2025
Merck held talks to buy biotech MoonLake for over $3 billion, FT reports
6/2/2025
Vera shares skyrocket as kidney disease drug succeeds in late-stage trial
6/2/2025
23andMe founder aims to restart auction with major corporate backing
6/1/2025
Gilead's CAR-T cell therapy shows promise in deadly brain cancer
By Julie Steenhuysen
6/1/2025
Gilead's Trodelvy, with Keytruda, cuts breast cancer risk by 35% in trial
By Deena Beasley
5/31/2025
Pfizer-Arvinas breast cancer drug tops AstraZeneca's in delaying progression
5/31/2025
Hims to cut 4% of workforce amid ban on weight-loss drug copies
By Amina Niasse
5/31/2025
Gilead commits to HIV prevention rollout for low-income countries despite funding uncertainty
By Julie Steenhuysen and Deena Beasley
5/30/2025
Regeneron shares slide on mixed trial data for smoker's lung drug
By Sriparna Roy
5/30/2025
US CDC continues to recommend COVID vaccines for children, contradicts Kennedy
5/30/2025
US FDA approves Moderna's next-generation COVID vaccine for adults 65 or older
By Chandni Shah, Mariam Sunny and Christy Santhosh
5/30/2025
Merck, Daiichi pull US application for 'guided missile' therapy for lung cancer
5/29/2025
Express Scripts sues to block Arkansas law barring PBM ownership of pharmacies
By Diana Novak Jones
5/29/2025
Trump administration report on US child health cited nonexistent studies, media report says
By Renee Hickman
5/29/2025
Stealth Bio to cut jobs after FDA rejects therapy for rare disorder
By Sriparna Roy
5/29/2025
Cooper Companies raises 2025 profit forecast on contact lens demand
5/29/2025
Drug developer iTeos winds down after cancer therapy setback
By Kamal Choudhury
5/28/2025
GSK, Spero stop UTI drug trial after early success
5/28/2025
US likely to resume Mexican cattle imports by year end, USDA chief veterinarian says
By Sybille de La Hamaide
5/28/2025
Boston Scientific to stop heart device sales amid regulatory challenges
5/28/2025
PepGen to discontinue development of experimental Duchenne therapy; shares drop
5/28/2025
FDA halts Rocket Pharma's gene therapy trial as patient dies
By Kamal Choudhury and Christy Santhosh
5/27/2025
US drops COVID vaccine recommendations for healthy children, pregnant women
5/27/2025
Measles cases in Texas rise by one to 729, state health department says
5/27/2025
Missouri Supreme Court allows abortion ban to continue
By Daniel Trotta
5/27/2025
US FDA approves use of Sanofi's meningococcal vaccine in infants
By Mariam Sunny and Siddhi Mahatole
5/27/2025
Eli Lilly to buy privately held SiteOne in deal worth up to $1 billion
5/27/2025
US to increase oversight on Medicaid use for immigrant healthcare
5/27/2025
Brazil confident it can seal regional trade deals with EU, US despite bird flu
By Sybille de La Hamaide
5/27/2025
RFK Jr., Argentine health minister slam WHO as their countries affirm withdrawal
5/27/2025
Swiss president to hold talks in Ireland amid US focus on pharma industry
Denis Balibouse
5/26/2025
Quadria Capital secures $1.07 billion for third Asia healthcare fund
5/26/2025
Measles cases in Texas rise by six to 728, state health department says
5/23/2025
Trump administration must restore health articles scrubbed for transgender mentions, judge rules
By Nate Raymond
5/23/2025
Caris Life Sciences discloses rise in revenue in US IPO filing
5/23/2025
Moderna files for review of updated COVID vaccine
5/23/2025
ISS backs Dynavax directors in board fight with Deep Track Capital
By Svea Herbst-Bayliss
5/23/2025
Americans scramble as weight-loss drug discounts fall short, copies face crackdown
By Sriparna Roy
5/23/2025
Factbox-Top cases before the US Supreme Court
5/22/2025
US farm agency to allow Iowa, Indiana to bar junk food and soda from food aid
By Leah Douglas
5/22/2025
White House 'MAHA' report calls out food, chemicals impact on children's health
By Leah Douglas, Michael Erman and Renee Hickman
5/22/2025
GSK's asthma drug wins FDA approval to treat 'smoker's lung'
By Siddhi Mahatole and Sriparna Roy
5/22/2025
GLP-1 diabetes drugs like Ozempic may modestly reduce cancer risks
By Nancy Lapid
5/22/2025
Insight Partners-backed Hinge Health valued at $3.7 billion in strong NYSE debut
By Pritam Biswas
5/22/2025
Trump administration proposes cutting Food and Drug Administration budget by 5.5%
5/22/2025
Brazil hopes to be officially free of bird flu in 28 days
By Ana Mano and Roberto Samora
5/22/2025
COVID shots should target newer strains of JN.1 variant in 2025-26 campaign, US FDA advisers say
5/22/2025
Medtronic to separate diabetes business following recent struggles
By Kamal Choudhury and Puyaan Singh
5/21/2025
Moderna pulls application for COVID-flu combination shot
5/21/2025
Factbox-Brazil trade restrictions after bird flu outbreak
5/21/2025
US CDC approves recommendations for chikungunya vaccines
5/21/2025
Health Rounds: Older diabetes drugs appear to slow prostate cancer in small study
By Nancy Lapid
5/21/2025
UnitedHealth falls after report it secretly paid nursing homes to reduce hospital transfers
By Sriparna Roy
5/21/2025
Mayne Pharma slumps 30% as Cosette threatens to scrap $432 million deal
5/21/2025
Cigna to offer $200 Wegovy, Zepbound weight-loss benefit
By Amina Niasse
5/21/2025